论文部分内容阅读
我院于1990年3月起用广东省汕头经济特区(鱼它)滨制药厂(华明医药有限公司)生产的阿霉素制剂,进行小批量临床试用,限于时间短促,现仅就使用过程中的毒副反应小结如下:病例来源患者均为安徽省肿瘤医院和中国癌症研究基金会安徽肿瘤康复医院的住院病人,共7例,男性5例,女性2例。年龄为53～64岁。其中胃癌2例(胰腺及肝转移各1例)、乳腺癌2例(均有锁骨上淋巴结转移,一例还有胸膜转移),直肠癌肝转移1例,胃癌术后复发2例及原发性肝癌1例。上述患者
In March 1990, our hospital began using the adriamycin preparations produced by the Shantou Special Economic Zone of Guangdong Province (Yu-Ting) Bin Pharmaceutical Factory (Huahing Pharmaceutical Co., Ltd.) for clinical trials in small batches. The toxicities and side effects were summarized as follows: The patients of the case were all inpatients from Anhui Cancer Hospital and Anhui Cancer Rehabilitation Hospital of the Chinese Cancer Research Foundation. There were 7 cases, 5 males and 2 females. Age is 53-64 years old. There were 2 cases of gastric cancer (1 case of pancreas and liver metastasis), 2 cases of breast cancer (all with supraclavicular lymph node metastasis, 1 case had pleural metastasis), 1 case of rectal cancer liver metastases, 2 cases of postoperative recurrence of gastric cancer, and primary One case of liver cancer. The above patients